Caroline Hendry, PhD

Caroline is the Scientific Director and Advisor to the Chair of Genetics at Yale School of Medicine. She is also the Director of the Office for Strategic Research Development, responsible for increasing research discovery and impact through strategic portfolio planning, advisory and collaboration. Caroline leads cross-functional capacity building activities in high growth areas including rare disease research, population/preventative health screening, and IND-enabling R&D for gene and cell-based therapies. She plays a key role in enabling highly efficient operational processes/systems across basic and clinical research.

Caroline was born in Brisbane, Australia and earned her undergraduate degree in Genetics at the University of Queensland, Australia. She earned her PhD under Prof Melissa Little at the Institute for Molecular Bioscience and went on to do a post-doc with Prof Ihor Lemishka at the Mount Sinai School of Medicine, NY, specialising in stem cells and reprogramming. Following her postdoc, Caroline moved to Cambridge, UK, where she took on a new role as Reviews Editor for the journal Development, covering the stem cells and regeneration fields.

Caroline was recruited to Yale in 2018 where she is responsible for increasing scientific impact and discovery in the Department of Genetics, bridging both basic and clinical research. A key aspect of the role is to foster interactions with Genetics faculty and other key stakeholders in genetics and genomics to develop and implement the scientific vision of the department and create strategic collaborations across Yale School of Medicine, Yale University, and industry. The role also provides leadership in driving new projects and programs to further the Department's mission and to translate existing research into new opportunities for growth.